Duane Valz – Zymergen Inc.
- Written by: Jim Cavan
- Produced by: Tania Doles
- Est. reading time: 5 mins
For Duane Valz, being the general counsel of Zymergen—a company on the cutting edge of bioengineering—is hardly a step backward from leading IP initiatives for Google, a role that included overseeing some of the most influential patent transactions in the technology sector—period.
Granted, it’s a very different type of company whose legal operations he now oversees.
Zymergen, a startup located just outside of Berkeley, California, is equal parts technology and biology. Founded in 2013, it promises novel products and materials created through fermentation, without the use of petroleum or petroleum derivatives.
The first of those products—whose details are currently under wraps—is in the final development phases and the company is solidifying partnerships to bring it to market. And, according to the energetic Valz, it is well worth the wait.
“Between climate change and the environmental impact of the materials we use, there are a lot of challenges we face, both as a planet and as a species,” he says. “What Zymergen is focused on is nothing short of supporting a new industrial revolution that addresses the biggest challenges of our time.”
The great unknown
Unlike conventional manufacturing, with workers in helmets and robots cranking out materials, microorganisms will be used in making the products, everything from super fabrics to plastic alternatives. In some instances, the microorganisms themselves will be the products—imagine, for instance, microscopic critters that consume oceanic trash.
With something this novel, agencies like the Environmental Protection Agency (EPA) may be expected to employ a high level of scrutiny.
“We’re not fundamentally altering existing organisms, but we are engineering microbes to create novel molecules that regulators aren’t familiar with,” Valz explains. “We believe in being transparent and collaborative, because this is uncharted terrain for everyone.”
Zymergen is slated to bring its first, top-secret product to market in 2020, but Valz says the company’s current pipeline of molecules and potential product applications currently number in the dozens. As with any innovator, protecting IP is key.
“A lot of companies find themselves in a position where they’re off the ground and gaining traction but, for one or another reason, are on their back heels when it comes to IP,” Valz says. “There’s a too-late factor to it. If you want to build a strategic IP portfolio, it behooves you to understand the nuances and do things right from the ground up.”
For which, Valz got an early start.
Controlling the tools
As an undergrad at the University of California, Berkeley, Valz became enthralled with the history and philosophy of science, and the whys and what-ifs of the tech-centric world around him. For Valz, asking what can science achieve, must always lead to a second, equally important question: Should it?
“It’s easy in certain cutting-edge technologies, where you’re faced with a lot of unknowns, to speculate about worst-case scenarios,” Valz explains. “But what I’ve always found is, when you talk to the scientists behind these ideas, they have a very sober and grounded view of what it is they’re doing and why.”
After earning his bachelor’s degree, Valz remained in Berkeley, where he received his J.D. in 1996—with a focus on law, technology and intellectual property.
He began his career in private practice, serving as associate attorney for the San Francisco firm of Howard Rice Nemerovski Canady Falk & Rabkin (since acquired by Arnold & Porter Kaye Scholer) from 1996 to 2000.
Valz initially left to work on a law-focused startup with one of his former clients, but that opportunity vanished with the dot-com bust in the spring of 2000. The following year, Valz made the transition in-house, as IP counsel for NextCard, the world’s first online-based credit card issuer.
In 2003, Valz joined Quantum Corporation as senior counsel, becoming the company’s director of intellectual property shortly therafter. As chair of Quantum’s patent review committee, Valz managed a then growing portfolio of patents and trademarks, all while developing creative commercialization strategies for the company’s legacy and newly developed IP assets.
In 2006, Valz was hired as vice president and associate general counsel of global patents for Yahoo. Leading a team of attorneys and engineers, he spearheaded a global invention initiative that helped transform the company’s patent position, expanding its filings to many hundreds per year and broadening technology coverage from basic web and messaging, to search, mobile, video, social media and cloud computing. Yahoo’s portfolio has since generated billions of dollars in direct monetization and enterprise value.
Following a two-year return to private practice, Valz joined Google in 2011, just as the smart phone wars were heating up. Working in the company’s patent department, Valz oversaw a number of landscape-altering tech patent transactions. These include the multi-company, industry-wide licensing of the Rockstar patent portfolio (acquired from Nortel Networks out of bankruptcy); positioning of the Motorola patent portfolio for supporting the Android ecosystem (e.g., through cross licenses with Samsung and LGE); the Open Patent Non-Assertion (OPN) Pledge; and a number of confidential patent purchase and cross license transactions worth hundreds of millions of dollars.
By all accounts, Valz had it made—a growing family, a beautiful home and a high-level job working for one of the world’s most influential companies. But during a chance encounter with Josh Hoffman, Zymergen’s CEO, Valz quickly realized just how wide open the world of bioengineering had become. Zymergen was undertaking to greatly advance the field by combining cutting edge biology with machine learning and automation. Valz was in.
In 2016, Valz was named vice president and general counsel. And while the title was a mutual first, it’s one Valz believes was a natural next step.
“Having an IP background isn’t a traditional route one takes to becoming a GC,” Valz says. “But we’ve arrived at a place where IP assets are recognized to have their own value apart from and above how it supports the business; there’s a marketplace for patents and that increases the enterprise value of patents and the importance of having a comprehensive IP strategy. And when you’re in an emerging market like we are, that can be a huge difference-maker.”
In addition to overseeing Zymergen’s IP strategy, Valz’s GC role allows him to navigate complex commercial transactions with the company’s customers and business partners and oversee cutting-edge regulatory issues.
“This GC role allows me to expand the types of issues I manage at the intersection of law, business and technology,” he says.
Showcase your feature on your website with a custom “As Featured in Vanguard” badge that links directly to your article!
Copy and paste this script into your page coding (ideally right before the closing